About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETED

Real-World Study of Helicobacter Pylori Eradication Success and Its Determinants

Study on the Real-World Eradication Success Rate of Helicobacter Pylori Infection and Its Influencing Factors

NCT07374822•Run-hua Li

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HELICOBACTER PYLORI INFECTIONS

Interventions

No Study-Assigned Intervention

Locations

1

China

Locations (1)

Shenzhen Hospital of Southern Medical University

Shenzhen, Guangdong, China

Key Dates

Start Date

May 1, 2024

Primary Completion Date

May 31, 2025

Completion Date

May 31, 2025

Last Updated

January 29, 2026

Related Studies

Registry for the Management of Helicobacter Pylori Infection in Shandong Province

NCT07335406

HELICOBACTER PYLORI INFECTIONS

Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

NCT07179159

HELICOBACTER PYLORI INFECTIONS

RECRUITINGPhase 2

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

NCT07293910

HELICOBACTER PYLORI INFECTIONSHelicobacter Infection+2 more

RECRUITINGPhase 4

Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality

NCT02047994

Helicobacter Pylori InfectionsAtrophic Gastritis+1 more

Not Yet Recruiting

Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound

NCT07458490

Peptic Ulcer DiseaseHELICOBACTER PYLORI INFECTIONS+3 more

Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication

NCT07333001

HELICOBACTER PYLORI INFECTIONS

View all related studies

Sponsors

Lead Sponsor

Run-hua Li

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions